Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000004

Chairperson & CEO sold 9,500 shares at an average $489.91 ($4,654,129)

  • Chairperson & CEO sold 9,500 shares at $146.03 ($1,387,285)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-04 Sale : show line 1 in the form 10b5-1 +9,500 $146.03 $1,387,285 9,630 D
2026-03-04 Sale : show line 2 in the form 10b5-1 −399 $486.42 $194,083 9,231 D
2026-03-04 Sale : show line 3 in the form 10b5-1 −926 $487.55 $451,475 8,305 D
2026-03-04 Sale : show line 4 in the form 10b5-1 −2,429 $488.63 $1,186,882 5,876 D
2026-03-04 Sale : show line 5 in the form 10b5-1 −2,290 $489.68 $1,121,367 3,586 D
2026-03-04 Sale : show line 6 in the form 10b5-1 −1,808 $490.52 $886,858 1,778 D
2026-03-04 Sale : show line 7 in the form 10b5-1 −485 $491.33 $238,296 1,293 D
2026-03-04 Sale : show line 8 in the form 10b5-1 −243 $492.44 $119,663 1,050 D
Open-market sales · 19,000 sh · avg $317.97 · $6,041,414

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-04 Exercise or conversion : show line 13 in the form 10b5-1 Stock Options −9,500 211,500 D
Loading xslF345X05/primarydocument.xml…